Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Michael A. Davies
Based on 109 articles published since 2007
||||
Expertise Level
The expertise of Michael A. Davies ranks in the
  • Top 0.042%
  • ... of 104,046 published authors worldwide on Melanoma
  • ... from 2007 through 2018
  • ... based on contributions to 109 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Davies, Michael A   ·   Davies, M A
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2018
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France. · Centre d'Investigation Clinique Biothérapie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 29097493
2017
  • The Wistar Institute, Philadelphia, PA, 19104, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Department of Pathology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · New Jersey Institute of Technology, Newark, NJ, 07102, USA. · Department of Dermatology and Venereology, Karl Landsteiner University of Health Sciences, St. Pölten, A-3100, Austria. · Department of Radiology, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Dermatology and Venereology, The Rudolfstiftung Hospital, Teaching Hospital of the Medical University Vienna, Vienna, A-1030, Austria. · Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, A-5020, Austria. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02115, USA. · Melanoma Institute of Australia, and The University of Sydney, Sydney, 2065, Australia. · Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Abramson Cancer Center, Hospital of University of Pennsylvania, Philadelphia, PA, 19104, USA. · SRI International, Menlo Park, CA, 94025, USA. · CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, A-1090, Austria. · Department of Biochemistry, McGill University, Montreal, QC, Canada, H3A0G4. · Dermatology Research Center, University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, 4102, Australia. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer, Center, Houston, TX, 77040, USA. · Moffitt Cancer Center, Tampa, FL, 33612, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · Pubmed 28928360
  • Department of Dermatology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany; German Cancer Consortium, 69117 Heidelberg, Germany. Electronic address: · Melanoma Institute Australia, The University of Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. · Moscow City Oncology Hospital No 62, Moscow 143423, Russia. · Przychodnia Lekarska KOMED, Wojska Polskiego 6, 62-500 Konin, Poland. · Department of Dermatology, University Medical Center Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany. · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Via Gattamelata 64, 35128 Padova, Italy. · Oncology Division, Sheba Medical Center, Tel HaShomer, Emek HaEla St 1, Ramat Gan, Israel. · Department of Dermatology, University of Tübingen, Geschwister-Scholl-Platz, 72074 Tübingen, Germany. · Service de Dermatologie et Dermatologie Pédiatrique, Hôpital Saint-André, 1 Rue Jean Burguet, 33000 Bordeaux, France. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens 157 72, Greece. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Cancer Immunology, Poznan University of Medical Sciences, 15 Garbary Street, 61-866 Poznań, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland. · Department of Dermatology, University Hospital Center, Timone Hospital, Aix Marseille University, 264 Rue St Pierre, 13885 Marseille Cedex 05, France. · Mount Vernon Cancer Centre, Rickmansworth Road, HA6 2RN Northwood, UK. · Department of Medicine, Hematology/Oncology, UCLA Medical Center, 100 UCLA Medical Plaza, Suite 550, Los Angeles, CA, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston 02114, MA, USA. · Department of Medical Oncology, Dermatology Service, Gustave Roussy Comprehensive Cancer Center and Faculty of Medicine, University Paris-South, F-94805, Villejuif, France. · Pubmed 28648698
  • Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Service de Dermatologie Générale et Oncologique, Hôpital A Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt, France; EA 4340, Université Versailles Saint-Quentin-en-Yvelines, Boulogne Billancourt, France. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Medical Oncology, Hospital Clinic of Barcelona, Carrer de Villarroel, Barcelona, Spain. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · Service de Dermatologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Oncologie Dermatologique, Centre Eugène Marquis, Rennes, France. · Clinique de Dermatologie, Unité d'Onco-Dermatologie, Le Centre Hospitalier Régional Universitaire de Lille, University Lille 2, Lille, France. · Melanoma Program, Medical Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Clinical Cancer Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada. · Servicio de Oncología Médica; Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Hôpital Saint Louis Paris, Paris, France. · Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 28592387
  • Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, North Sydney, Australia. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, USA. · Moscow City Oncology Hospital #62, Moscow, Russia. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens, Greece. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · Dipartimento di Medicina Oncologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Department of Dermatology, University of Tübingen, Tübingen, Germany. · Service D'oncologie Médicale, Hopital Francois Mitterrand, Pau, France. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Medical Oncology Department, Sir Charles Gairdner Hospital, Perth, Australia. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Dnipropetrovsk State Medical Academy, Clinical Hospital #4, Dnipropetrovsk, Ukraine. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim and Heidelberg, Germany. · Department of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy. · Dermatologisches Zentrum Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany. · Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium, Heidelberg, Germany. · Mount Vernon Cancer Centre, Northwood, UK. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Department of Medicine, Hematology/Oncology, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Novartis Pharmaceuticals Corporation, East Hanover, USA. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix-Marseille Université, Marseille, France. · Pubmed 28475671
  • Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY, USA. · Departments of Oncological Sciences and Dermatology, 1470 Madison Avenue, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Institute of Systems Genetics, New York University Langone Medical Center, New York, NY, USA. · Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY, USA. Electronic address: · Departments of Oncological Sciences and Dermatology, 1470 Madison Avenue, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: · Pubmed 29149598
  • Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. · Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA. · Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, CA 90404, USA. · Helen F. Graham Cancer Center at Christiana Care, Newark, DE 19713, USA. · Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107. · Department of Dermatology, University Duisburg-Essen, University Hospital Essen, 45147 Essen, Germany; German Consortium of Translational Cancer Research, Heidelberg, Germany. · Lineberger Cancer Center, University of North Carolina Chapel Hill, NC 27514, USA. · Glaxosmithkline, Collegeville, PA 19426, USA. · Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA. · Bayer Pharma AG, Berlin 13353, Germany. · National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA. · Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. Electronic address: · Pubmed 29141225
  • Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · The Wistar Institute, Molecular and Cellular Oncogenesis Program, Tumor Microenvironment and Metastasis Program, and Melanoma Research Center, Philadelphia, PA, USA. · Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA. · Department of Medicine, Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Helen F. Graham Cancer Center at Christiana Care Health System, Newark, DE, USA. · Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, MA, USA. · Department of Translational Molecular Medicine, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA. · Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Perlmutter Cancer Center, NYU School of Medicine, NYU Langone Medical Center, New York, NY, USA. · Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: · Pubmed 29141224
  • Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, United States. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States; Department of Neurosurgery, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. Electronic address: · Pubmed 28916225
  • The Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania. · The University of the Sciences, Philadelphia, Pennsylvania. · The University of Pennsylvania, Philadelphia, Pennsylvania. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · The Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania. · Pubmed 28887323
  • Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, Texas. · Eugene McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center, Dallas, Texas. · The Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts. · Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, Texas. · Children's Research Institute and the Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas. · Manchester Cancer Research Centre, Wellcome Trust Centre for Cell-Matrix Research, The University of Manchester, Manchester, United Kingdom. · Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Institute, University of Sydney, Sydney, New South Wales, Australia. · Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, Texas. · Pubmed 28455392
  • Bioinformatics Interdepartmental Program, University of California, Los Angeles, CA 90095, USA; Department of Biological Chemistry, University of California, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, CA 90095, USA. · Division of Cancer Medicine, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. · Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA. · Division of Cancer Medicine, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Graduate Program in Structural and Computational Biology and Molecular Biophysics, Baylor College of Medicine, Houston, TX 77030, USA. · Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Biology, Boston University, Boston, MA 02215, USA. · Division of Cancer Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. · Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Division of Internal Medicine, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Weizmann Institute of Science, Rehovot 761001, Israel. · Division of Cancer Medicine, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Division of Cancer Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Institute for Health Transformation, The University of Texas System, Austin, TX 78701, USA. Electronic address: · Bioinformatics Interdepartmental Program, University of California, Los Angeles, CA 90095, USA; Department of Biological Chemistry, University of California, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, CA 90095, USA; Department of Computer Science, University of California, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095, USA; Molecular Biology Institute, University of California, Los Angeles, CA 90095, USA. Electronic address: · Division of Cancer Medicine, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. Electronic address: · Pubmed 28445736
  • Division of Molecular Oncology, Department of Translational Molecular Medicine, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California. · The David and Janet Polak Cancer and Vascular Biology Research Center, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Bat-Galim, Haifa, Israel. · John Wayne Cancer Institute Genome Sequencing Center, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Molecular Oncology, Department of Translational Molecular Medicine, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California. · Pubmed 28389511
  • Medical Scientist Training Program, Vanderbilt University Medical Center, Nashville, TN 37232 USA. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232 USA. · Division of Hematology/Oncology, Vanderbilt University Medical Center, 777 PRB, 2220 Pierce Ave, Nashville, TN USA. · Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL 33612 USA. · Sarcoma Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA. · Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232 USA. · Roswell Park Cancer Institute, Buffalo, NY 14263 USA. · Division of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057 USA. · Melanoma and Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA. · Weill Cornell Medical College, Cornell University, New York, NY 10065 USA. · Pubmed 28239462
  • Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania. · Pubmed 28138035
  • Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Clinical Research Program, California Pacific Medical Center, San Francisco, California. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27911979
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27864417
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia. · Royal North Shore and Mater Hospitals, Sydney, Australia. · Vanderbilt University Medical Center, Nashville, USA. · Princess Alexandra Hospital, Greenslopes Hospital and University of Queensland, Brisbane, Australia. · Peter MacCallum Cancer Centre, Melbourne, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, Australia. · The University of Texas MD Anderson Cancer Center, Houston, USA. · Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medical Oncology, University of California San Francisco, San Francisco, USA. · Department of Medical Oncology, Moffitt Cancer Centre, Tampa, USA. · Department of Medical Oncology, Olivia Newton-John Cancer Centre & Cancer Research Institute, Austin Health, Melbourne, Australia. · Department of Dermatology, Heidelberg University, Heidelberg, Germany. · Massachusetts General Hospital Cancer Center, Boston, USA. · Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, USA. · Pubmed 27687304
2016
  • Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. · Department of Melanoma, Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medical Oncology & Therapeutics Research, City of Hope Cancer Center, Duarte, CA, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA. · Division of Neuro-Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT, USA. · Department of Neurology & Herbert Irving Comprehensive, Cancer Center, Columbia University Medical Center, New York, NY, USA. · UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. · Department of Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY, USA. · Division of Neuro-Oncology, Department of Neurology, Stanford University, Stanford, CA, USA. · Department of Radiology, New York-Presbyterian Hospital - Weill Cornell Medicine, New York, NY, USA. · Department of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Cancer Biology & Genetics, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY, USA. · Melanoma Research Foundation, Washington, DC, USA. · Pubmed 27615400
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Departments of Pathology and Translational and Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston. · Broad Institute, Cambridge, Massachusetts. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston7Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · California Pacific Medical Center Research Institute, San Francisco. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston11Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27124486
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia. Electronic address: · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix Marseille Université, Marseille CEDEX 05, France. · Mount Vernon Cancer Centre, Northwood, UK. · Department of Medicine, Hematology/Oncology, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Biostatistics, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Global Oncology, Novartis Pharma AG, Basel, Switzerland. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MDAnderson Cancer Center, Houston, TX, USA. · Pubmed 27864013
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Lion Biotechnologies, Woodland Hills, CA, 91637, USA. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 770393, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · EMD Serono, Rockland, MA, 02370, USA. · Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 27776519
  • The Wistar Institute, Melanoma Research Center, Philadelphia, PA, USA. · Discovery Oncology Merck Research Laboratories, Boston, MA, USA. · Melanoma Medical Oncology and Systems Biology University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Medical Genetics and The Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia PA, USA. · Pubmed 27655717
  • Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. Department of Cutaneous Biology and Dermatology, Thomas Jefferson University, Philadelphia, Pennsylvania. · Pubmed 27488531
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27301722
  • Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Medicine and Dermatology, University of Arizona Cancer Center, Tucson, AZ, USA. · Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA. · Department of Dermatology, Knight Cancer Institute Melanoma and Skin Cancer Program, Oregon Health Science University, Portland, OR, USA. · Molecular Oncology Program, Melanoma Laboratory, CNIO, Madrid, Spain. · Department of Dermatology, Huntsman Cancer Institute, Salt Lake City, UT, USA. · Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. · Department of Dermatology, Stanford University Medical Center and Cancer Institute/VA Palo Alto Health Care System, Palo Alto, CA, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Dermatology and Dermatopathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Dermatology, University of Zurich, Zürich, Switzerland. · Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Melanoma and Skin Cancer Program, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Pathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Medical Oncology and Dermatology, University of California Los Angeles, Los Angeles, CA, USA. · Melanoma Institute, University of Sydney, Sydney, NSW, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical School, Nashville, TN, USA. · Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Women Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Program, Department of Dermatology, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Melanoma and Pigmented Lesion Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Dermatology, University of Bonn, Bonn, Germany. · Melanoma Research Foundation, Washington, DC, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. · Pubmed 27087480
  • Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University Philadelphia, Pennsylvania, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. · Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University Philadelphia, Pennsylvania, USA; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Electronic address: · Pubmed 26967478
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Dermatology, School of Medicine, Keio University, Tokyo, Japan. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, California. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology and Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26783288
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Chicago, Chicago, Illinois. · Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26645196
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
2015
  • The University of Texas, MD Anderson Cancer Center, Houston, Texas. · Pubmed 27058849
  • The University of Texas MD Anderson Cancer Center, Houston, Texas. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Sarah Cannon Research Institute at HealthONE, Denver, Colorado. · Eisai Inc., Oncology, Woodcliff Lake, New Jersey. · Former employees of Eisai Inc., Woodcliff Lake, New Jersey. · Mary Crowley Cancer Research Center, Dallas, Texas. · Pubmed 26169970
  • Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. · Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montréal, Canada. Department of Oncology, McGill University, Montréal, Canada. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, NCI, Bethesda, Maryland. · Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. · Cancer and Cell Biology Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · Departments of Dermatology and Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. · Pubmed 26603897
  • Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Hormel Institute, University of Minnesota, Austin, MN 55912, USA. · Department of Chemistry, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. Electronic address: · Pubmed 26565903
  • Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26216417
  • Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. · Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · ImmunoGen, Inc., Waltham, Massachusetts. · The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York. The Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, New York. · Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Pubmed 26206558
  • Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA, USA. · Pubmed 26176707
  • University of Texas MD Anderson Cancer Center, Houston, TX, 77030, U.S.A. · Pubmed 26174638
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Electronic address: · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Electronic address: · Pubmed 26058727
  • Department of Melanoma Medical Oncology, Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25877344
  • Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25795007
  • Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The Eli and Edythe L. Broad Institute of Massachusetts, Institute of Technology and Harvard University, Cambridge, Massachusetts, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25754356
  • Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, California. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, NCI, Bethesda, Maryland. · Cancer and Cell Biology Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · Department of Dermatology, Yale University, School of Medicine, New Haven, Connecticut. Department of Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Department of Dermatology, Yale University, School of Medicine, New Haven, Connecticut. · Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, California. · Pubmed 25712345
  • Department of Dermatology, Yale University, New Haven, CT 06510, USA. Electronic address: · Department of Dermatology, Yale University, New Haven, CT 06510, USA; Department of Pathology, Yale University, New Haven, CT 06510, USA. · Department of Pathology, Yale University, New Haven, CT 06510, USA. · Department of Chemistry, Yale University, New Haven, CT 06510, USA. · Department of Emergency Medicine, The Warren Alpert Medical School of Brown University, Providence, RI 02912, USA. · Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06510, USA. · Section of Comparative Medicine, Yale University School of Medicine, New Haven, CT 06510, USA. · Department of Dermatology, Yale University, New Haven, CT 06510, USA. · Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA 19140, USA. · NextGen Sequencing Facility, Vermont Cancer Center, University of Vermont, College of Medicine, Burlington, VT 05405, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biology, McGill University, Montreal, QC H3G OB1, Canada. · Helen Diller Family Comprehensive Cancer Center and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA. · Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. · Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA 02114, USA. · Department of Dermatology, Yale University, New Haven, CT 06510, USA; Department of Pathology, Yale University, New Haven, CT 06510, USA. Electronic address: · Pubmed 25584893
  • Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Dermatology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Cancer Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Experimental Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. Electronic address: · Pubmed 25148578
2014
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 904, Houston, TX 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 904, Houston, TX 77030, USA. Electronic address: · Pubmed 24880945
  • Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States. Electronic address: · Pubmed 24291778
  • Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · 1] Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23416974
  • Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America. · Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America. · Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America. · Department of Surgical Oncology and Genomic Medicine, University of Texas, M.D.Anderson Cancer Center, Houston, Texas, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, United States of America. · Pubmed 24983357
  • Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Melanoma Institute of Australia and Westmead Hospital, Sydney, Australia. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pediatrics, University of Cincinnati, Cincinatti, Ohio. · Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Astra Zeneca, Macclesfield, United Kingdom. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Pubmed 25297634
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25165098
  • Department of Genomic Medicine The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China. · Department of Cancer Biology The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Systems Biology The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Dermatology The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Melanoma Medical Oncology The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Institute for Applied Cancer Science The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 25056119
  • Department of Cancer Biology and Kimmel Cancer Center; Jefferson College of Graduate Studies; · Department of Cancer Biology and Kimmel Cancer Center; · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; and. · ImmunoGen, Inc., Waltham, Massachusetts. · Department of Cancer Biology and Kimmel Cancer Center; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania; · Pubmed 25035390
  • Departments of Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24795008
  • The Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia. · Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA. · Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · NIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Division of Medical Oncology, University of Colorado School of Medicine, Aurora, Colorado, USA. · The Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · Genome Informatics Section, Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · The Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: · Pubmed 24008424
2012
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22453015
  • Department of Surgery, Duke University, Durham, NC. · Department of Pathology, Duke University, Durham, NC. · Cancer Center Biostatistics, Duke University, Durham, NC. · Department of Surgery, Memorial Sloan Kettering Cancer Center, New York. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. · Department of Systems Biology, MD Anderson Cancer Center, Houston, Texas. · VA Medical Center, Durham, NC. · Pubmed 22549288
  • Departments of Melanoma Medical Oncology, Systems Biology, Biostatistics, Pathology, Experimental Therapeutics, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22223528
2011
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 7455 Fannin, 1SCRB2.3019, Unit 0904, Houston, TX 77054, USA. · Pubmed 21111965
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 20960525
2010
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 20697348
2008
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 18813315
2017
  • From the Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28114258
  • aThe Hormel Institute, University of Minnesota, Austin, Minnesota bDepartment of Medicine and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania Departments of cOncological Sciences dSurgery eDermatology fHuntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah gDepartment of Tumor Biology, Tumor Biology hDepartment of Cutaneous Oncology, Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida iDepartment of Medicine, Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital jDepartment of Global Health, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, DC kDepartment of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 29076949
2016
  • Departments of aMelanoma Medical Oncology bBiostatistics cSystems Biology, UT MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 27540836
  • From the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl); · the Department of Pathology, University of Michigan Hospitals, Ann Arbor (Dr Andea); · the Department of Pathology, University of Nebraska Medical Center, Omaha (Dr Bridge); · the Department of Pathology, Indiana University, Indianapolis (Dr Cheng); · the Departments of Melanoma Medical Oncology and Systems Biology (Dr Davies). · Pathology (Drs Lazar and Siroy), and Translational Molecular Pathology (Dr Lazar). · The University of Texas MD Anderson Cancer Center, Houston, Texas; Newport Coast Pathology Inc, Newport Beach, California (Dr Ehteshami); · the Department of Medicine and the Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia (Dr Gangadhar); · the Department of Pathology, The University Health Network/Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Kamel-Reid); · the Department of Pathology, Northwestern University, Chicago, Illinois (Dr Raparia); and Cancer Registry Consultant, Sioux Falls, South Dakota (Ms Watson). · and Cancer Registry Consultant, Sioux Falls, South Dakota (Ms Watson). · Pubmed 26340412
2015
  • Departments of *Surgery †Radiation Oncology and Biomedical Engineering, Duke University, Durham, NC; and ‡Departments of Melanoma Medical Oncology and Systems Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX. · Pubmed 24646553
2014
  • aHealth Science Center, University of Oklahoma, Oklahoma City, Oklahoma Departments of bMelanoma Medical Oncology cPalliative Care and Rehabilitative Medicine dBiostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24743052
  • Authors' Affiliations: Departments of Otolaryngology, Dermatology, Immunology, and Oncological Sciences; Division of Hematology and Oncology, Department of Medicine, Department of Otolaryngology, The Tisch Cancer Institute, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai; The Tisch Cancer Institute; Department of Genetics and Genomic Sciences, One Gustave L. Levy Place, New York, New York; and Departments of Melanoma Medical Oncology and Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24398473
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 24259006
2013
  • Authors' Affiliations: Departments of Genomic Medicine, Melanoma Medical Oncology, and Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24089444
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22972589
  • Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 23922205
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 23273605
  • Departments of Melanoma Medical Oncology and Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23204132
2012
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22275506
  • Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23032743
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22809251
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22850568
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22733540
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 22584956
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22465753
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22180178
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22171948
  • Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 22130161
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22020736
  • Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 21792892
2010
  • Departments of Melanoma Medical Oncology and Systems Biology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20457136
  • Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20959481
  • Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20215556
2009
  • Department of Melanoma Medical Oncology and Department of Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19671763
Probable:    Miscellaneous institutions in Sao Paulo      
2016
  • Department of Cell and Molecular Biology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · National Institute of Science and Technology in Stem Cell and Cell Therapy and Center for Cell-Based Therapy, Ribeirão Preto, São Paulo, Brazil. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Clinical Oncology, Stem Cell and Cell Therapy Program, Ribeirão Preto Medical School, Ribeirão Preto, São Paulo, Brazil. · Department of Genetics, Ribeirão Preto Medical School, and Center for Integrative System Biology (CISBi-NAP/USP), University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · Pubmed 27167340
Probable:    Miscellaneous institutions in Ribeirao Preto      
2016
  • Department of Cell and Molecular Biology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · National Institute of Science and Technology in Stem Cell and Cell Therapy and Center for Cell-Based Therapy, Ribeirão Preto, São Paulo, Brazil. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Clinical Oncology, Stem Cell and Cell Therapy Program, Ribeirão Preto Medical School, Ribeirão Preto, São Paulo, Brazil. · Department of Genetics, Ribeirão Preto Medical School, and Center for Integrative System Biology (CISBi-NAP/USP), University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · Pubmed 27167340
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 109 total) written by Michael A. Davies about Melanoma:

  • Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. 2018
  • Melanoma Brain Metastases: Current Areas of Investigation and Future Directions. 2017
  • Tumor-associated B-cells induce tumor heterogeneity and therapy resistance. 2017
  • Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. 2017
  • Dabrafenib plus trametinib in patients with BRAF 2017
  • Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study. 2017
  • Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene. 2017
  • A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. 2017
  • Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines. 2017
  • Resistance mechanisms to genetic suppression of mutant NRAS in melanoma. 2017
Show List of Full Article Records
Google Searches

Learn more about Michael A. Davies using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
Miscellaneous institutions in Sao Paulo
Miscellaneous institutions in Ribeirao Preto
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2018
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France. · Centre d'Investigation Clinique Biothérapie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 29097493
2017
  • The Wistar Institute, Philadelphia, PA, 19104, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Department of Pathology and Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · New Jersey Institute of Technology, Newark, NJ, 07102, USA. · Department of Dermatology and Venereology, Karl Landsteiner University of Health Sciences, St. Pölten, A-3100, Austria. · Department of Radiology, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Biomedical Imaging and Image-guided Therapy, Division of Nuclear Medicine, Medical University of Vienna, Vienna, A-1090, Austria. · Department of Dermatology and Venereology, The Rudolfstiftung Hospital, Teaching Hospital of the Medical University Vienna, Vienna, A-1030, Austria. · Department of Dermatology, Paracelsus Medical University Salzburg, Salzburg, A-5020, Austria. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77040, USA. · Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02115, USA. · Melanoma Institute of Australia, and The University of Sydney, Sydney, 2065, Australia. · Department of Bioengineering, University of Pennsylvania, Philadelphia, PA, 19104, USA. · Abramson Cancer Center, Hospital of University of Pennsylvania, Philadelphia, PA, 19104, USA. · SRI International, Menlo Park, CA, 94025, USA. · CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, A-1090, Austria. · Department of Biochemistry, McGill University, Montreal, QC, Canada, H3A0G4. · Dermatology Research Center, University of Queensland Diamantina Institute, The University of Queensland, Translational Research Institute, Brisbane, 4102, Australia. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer, Center, Houston, TX, 77040, USA. · Moffitt Cancer Center, Tampa, FL, 33612, USA. · The Wistar Institute, Philadelphia, PA, 19104, USA. · Division of Immunology, Allergy and Infectious Diseases (DIAID), Department of Dermatology, Medical University of Vienna, Vienna, A-1090, Austria. · Pubmed 28928360
  • Department of Dermatology, University Hospital Essen, Hufelandstrasse 55, 45122 Essen, Germany; German Cancer Consortium, 69117 Heidelberg, Germany. Electronic address: · Melanoma Institute Australia, The University of Sydney, NSW, Australia; Mater Hospital, North Sydney, NSW, Australia; Royal North Shore Hospital, St Leonards, NSW, Australia. · Moscow City Oncology Hospital No 62, Moscow 143423, Russia. · Przychodnia Lekarska KOMED, Wojska Polskiego 6, 62-500 Konin, Poland. · Department of Dermatology, University Medical Center Schleswig-Holstein, Arnold-Heller-Straße 3, 24105 Kiel, Germany. · Petrov Research Institute of Oncology, 68 Leningradskaya Street, Saint Petersburg 197758, Russia. · Melanoma and Esophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Via Gattamelata 64, 35128 Padova, Italy. · Oncology Division, Sheba Medical Center, Tel HaShomer, Emek HaEla St 1, Ramat Gan, Israel. · Department of Dermatology, University of Tübingen, Geschwister-Scholl-Platz, 72074 Tübingen, Germany. · Service de Dermatologie et Dermatologie Pédiatrique, Hôpital Saint-André, 1 Rue Jean Burguet, 33000 Bordeaux, France. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens 157 72, Greece. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Cancer Immunology, Poznan University of Medical Sciences, 15 Garbary Street, 61-866 Poznań, Poland. · Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Wawelska 15B, 02-034 Warsaw, Poland. · Department of Dermatology, University Hospital Center, Timone Hospital, Aix Marseille University, 264 Rue St Pierre, 13885 Marseille Cedex 05, France. · Mount Vernon Cancer Centre, Rickmansworth Road, HA6 2RN Northwood, UK. · Department of Medicine, Hematology/Oncology, UCLA Medical Center, 100 UCLA Medical Plaza, Suite 550, Los Angeles, CA, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston 77030, TX, USA. · Novartis Pharmaceuticals Corporation, 1 Health Plaza, East Hanover 07936, NJ, USA. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston 02114, MA, USA. · Department of Medical Oncology, Dermatology Service, Gustave Roussy Comprehensive Cancer Center and Faculty of Medicine, University Paris-South, F-94805, Villejuif, France. · Pubmed 28648698
  • Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Service de Dermatologie Générale et Oncologique, Hôpital A Paré, Assistance Publique-Hôpitaux de Paris, Boulogne Billancourt, France; EA 4340, Université Versailles Saint-Quentin-en-Yvelines, Boulogne Billancourt, France. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Medical Oncology, Hospital Clinic of Barcelona, Carrer de Villarroel, Barcelona, Spain. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · Service de Dermatologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France. · Oncologie Dermatologique, Centre Eugène Marquis, Rennes, France. · Clinique de Dermatologie, Unité d'Onco-Dermatologie, Le Centre Hospitalier Régional Universitaire de Lille, University Lille 2, Lille, France. · Melanoma Program, Medical Oncology, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA. · Clinical Cancer Research Unit, Princess Margaret Cancer Centre, Toronto, ON, Canada. · Servicio de Oncología Médica; Hospital General Universitario Gregorio Marañon, Madrid, Spain. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Hôpital Saint Louis Paris, Paris, France. · Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia. · Pubmed 28592387
  • Melanoma Institute Australia, The University of Sydney, and Royal North Shore and Mater Hospitals, North Sydney, Australia. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, USA. · Moscow City Oncology Hospital #62, Moscow, Russia. · First Department of Medicine, "Laiko" General Hospital, National and Kapodistrian University of Athens, Athens, Greece. · Petrov Research Institute of Oncology, Saint Petersburg, Russia. · Dipartimento di Medicina Oncologica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Royal Marsden NHS Foundation Trust, London, UK. · Department of Dermatology, University of Tübingen, Tübingen, Germany. · Service D'oncologie Médicale, Hopital Francois Mitterrand, Pau, France. · Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany. · Melanoma and Oesophageal Oncology Unit, Veneto Oncology Institute-IRCCS, Padova, Italy. · APHP Dermatology and CIC Departments, INSERM U976, University Paris Diderot, Paris, France. · Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy. · Medical Oncology Department, Sir Charles Gairdner Hospital, Perth, Australia. · Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain. · Dnipropetrovsk State Medical Academy, Clinical Hospital #4, Dnipropetrovsk, Ukraine. · Netherlands Cancer Institute, Amsterdam, The Netherlands. · Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. · Skin Cancer Unit, German Cancer Research Center (DKFZ) and Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karls University of Heidelberg, Mannheim and Heidelberg, Germany. · Department of Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy. · Dermatologisches Zentrum Buxtehude, Elbe Kliniken Buxtehude, Buxtehude, Germany. · Dnipropetrovsk Clinical Oncology Center of Dnipropetrovsk State Council, Dnipropetrovsk, Ukraine. · Department of Dermatology, University Hospital Essen, Essen, Germany. · German Cancer Consortium, Heidelberg, Germany. · Mount Vernon Cancer Centre, Northwood, UK. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Department of Medicine, Hematology/Oncology, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Novartis Pharmaceuticals Corporation, East Hanover, USA. · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix-Marseille Université, Marseille, France. · Pubmed 28475671
  • Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY, USA. · Departments of Oncological Sciences and Dermatology, 1470 Madison Avenue, Icahn School of Medicine at Mount Sinai, New York, NY, USA. · Institute of Systems Genetics, New York University Langone Medical Center, New York, NY, USA. · Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology and Interdisciplinary Melanoma Cooperative Group, New York University Langone Medical Center, New York, NY, USA. Electronic address: · Departments of Oncological Sciences and Dermatology, 1470 Madison Avenue, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: · Pubmed 29149598
  • Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. · Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · MD Anderson Cancer Center, University of Texas, Houston, TX 77030, USA. · Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA. · Translational Molecular Medicine, John Wayne Cancer Institute, Santa Monica, CA 90404, USA. · Helen F. Graham Cancer Center at Christiana Care, Newark, DE 19713, USA. · Ocular Oncology Service, Wills Eye Hospital, Philadelphia, PA 19107, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107. · Department of Dermatology, University Duisburg-Essen, University Hospital Essen, 45147 Essen, Germany; German Consortium of Translational Cancer Research, Heidelberg, Germany. · Lineberger Cancer Center, University of North Carolina Chapel Hill, NC 27514, USA. · Glaxosmithkline, Collegeville, PA 19426, USA. · Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA. · Bayer Pharma AG, Berlin 13353, Germany. · National Center for Advancing Translational Sciences, NIH, Rockville, MD 20850, USA. · Molecular and Cellular Oncogenesis Program, Wistar Institute, Philadelphia, PA 19104, USA. Electronic address: · Pubmed 29141225
  • Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · The Wistar Institute, Molecular and Cellular Oncogenesis Program, Tumor Microenvironment and Metastasis Program, and Melanoma Research Center, Philadelphia, PA, USA. · Department of Statistics, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA. · Department of Medicine, Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Helen F. Graham Cancer Center at Christiana Care Health System, Newark, DE, USA. · Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, MA, USA. · Department of Translational Molecular Medicine, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA. · Department of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, PA, USA. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Perlmutter Cancer Center, NYU School of Medicine, NYU Langone Medical Center, New York, NY, USA. · Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: · Pubmed 29141224
  • Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, United States. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States; Department of Neurosurgery, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. Electronic address: · Pubmed 28916225
  • The Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania. · The University of the Sciences, Philadelphia, Pennsylvania. · The University of Pennsylvania, Philadelphia, Pennsylvania. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Fox Chase Cancer Center, Philadelphia, Pennsylvania. · Melanoma Group, Molecular Oncology Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. · The Wistar Institute Melanoma Research Center, Philadelphia, Pennsylvania. · Pubmed 28887323
  • Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, Texas. · Eugene McDermott Center for Human Growth and Development, The University of Texas Southwestern Medical Center, Dallas, Texas. · The Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, Massachusetts. · Department of Biochemistry, The University of Texas Southwestern Medical Center, Dallas, Texas. · Children's Research Institute and the Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas. · Manchester Cancer Research Centre, Wellcome Trust Centre for Cell-Matrix Research, The University of Manchester, Manchester, United Kingdom. · Division of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Institute, University of Sydney, Sydney, New South Wales, Australia. · Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas, Texas. · Pubmed 28455392
  • Bioinformatics Interdepartmental Program, University of California, Los Angeles, CA 90095, USA; Department of Biological Chemistry, University of California, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, CA 90095, USA. · Division of Cancer Medicine, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. · Department of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, PA 19104, USA. · Division of Cancer Medicine, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Graduate Program in Structural and Computational Biology and Molecular Biophysics, Baylor College of Medicine, Houston, TX 77030, USA. · Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Biology, Boston University, Boston, MA 02215, USA. · Division of Cancer Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. · Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Division of Internal Medicine, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Weizmann Institute of Science, Rehovot 761001, Israel. · Division of Cancer Medicine, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Division of Cancer Medicine, Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA; Institute for Health Transformation, The University of Texas System, Austin, TX 78701, USA. Electronic address: · Bioinformatics Interdepartmental Program, University of California, Los Angeles, CA 90095, USA; Department of Biological Chemistry, University of California, Los Angeles, CA 90095, USA; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, CA 90095, USA; Department of Computer Science, University of California, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA 90095, USA; Molecular Biology Institute, University of California, Los Angeles, CA 90095, USA. Electronic address: · Division of Cancer Medicine, Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77054, USA. Electronic address: · Pubmed 28445736
  • Division of Molecular Oncology, Department of Translational Molecular Medicine, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California. · The David and Janet Polak Cancer and Vascular Biology Research Center, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Bat-Galim, Haifa, Israel. · John Wayne Cancer Institute Genome Sequencing Center, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Molecular Oncology, Department of Translational Molecular Medicine, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California. · Pubmed 28389511
  • Medical Scientist Training Program, Vanderbilt University Medical Center, Nashville, TN 37232 USA. · Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, TN 37232 USA. · Division of Hematology/Oncology, Vanderbilt University Medical Center, 777 PRB, 2220 Pierce Ave, Nashville, TN USA. · Department of Cutaneous Oncology, Moffitt Cancer Center and Research Institute, Tampa, FL 33612 USA. · Sarcoma Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA. · Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA. · Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN 37232 USA. · Roswell Park Cancer Institute, Buffalo, NY 14263 USA. · Division of Hematology/Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057 USA. · Melanoma and Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065 USA. · Weill Cornell Medical College, Cornell University, New York, NY 10065 USA. · Pubmed 28239462
  • Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania. · Pubmed 28138035
  • Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Clinical Research Program, California Pacific Medical Center, San Francisco, California. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27911979
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27864417
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia. · Royal North Shore and Mater Hospitals, Sydney, Australia. · Vanderbilt University Medical Center, Nashville, USA. · Princess Alexandra Hospital, Greenslopes Hospital and University of Queensland, Brisbane, Australia. · Peter MacCallum Cancer Centre, Melbourne, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, Australia. · The University of Texas MD Anderson Cancer Center, Houston, USA. · Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Medical Oncology, University of California San Francisco, San Francisco, USA. · Department of Medical Oncology, Moffitt Cancer Centre, Tampa, USA. · Department of Medical Oncology, Olivia Newton-John Cancer Centre & Cancer Research Institute, Austin Health, Melbourne, Australia. · Department of Dermatology, Heidelberg University, Heidelberg, Germany. · Massachusetts General Hospital Cancer Center, Boston, USA. · Division of Hematology-Oncology, University of California Los Angeles, Los Angeles, USA. · Pubmed 27687304
2016
  • Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA. · Department of Melanoma, Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Medical Oncology & Therapeutics Research, City of Hope Cancer Center, Duarte, CA, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Division of Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA. · Division of Neuro-Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT, USA. · Department of Neurology & Herbert Irving Comprehensive, Cancer Center, Columbia University Medical Center, New York, NY, USA. · UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. · Department of Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY, USA. · Division of Neuro-Oncology, Department of Neurology, Stanford University, Stanford, CA, USA. · Department of Radiology, New York-Presbyterian Hospital - Weill Cornell Medicine, New York, NY, USA. · Department of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Cancer Biology & Genetics, Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, New York, NY, USA. · Melanoma Research Foundation, Washington, DC, USA. · Pubmed 27615400
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Departments of Pathology and Translational and Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston. · Broad Institute, Cambridge, Massachusetts. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston7Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · California Pacific Medical Center Research Institute, San Francisco. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston11Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27124486
  • Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia. Electronic address: · Service de Dermatologie, Centre Hospitalo-Universitaire Timone, Aix Marseille Université, Marseille CEDEX 05, France. · Mount Vernon Cancer Centre, Northwood, UK. · Department of Medicine, Hematology/Oncology, UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. · Gustave Roussy, Département de Médecine Oncologique, Service de Dermatologie et Université Paris-Sud, Faculté de Médecine, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany; German Cancer Consortium, Heidelberg, Germany. · Biostatistics, Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Global Oncology, Novartis Pharma AG, Basel, Switzerland. · Developmental Therapeutics and Melanoma Programs, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Melanoma Medical Oncology and Systems Biology, The University of Texas MDAnderson Cancer Center, Houston, TX, USA. · Pubmed 27864013
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Lion Biotechnologies, Woodland Hills, CA, 91637, USA. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 770393, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · EMD Serono, Rockland, MA, 02370, USA. · Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 27776519
  • The Wistar Institute, Melanoma Research Center, Philadelphia, PA, USA. · Discovery Oncology Merck Research Laboratories, Boston, MA, USA. · Melanoma Medical Oncology and Systems Biology University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Medical Genetics and The Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia PA, USA. · Pubmed 27655717
  • Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. Department of Cutaneous Biology and Dermatology, Thomas Jefferson University, Philadelphia, Pennsylvania. · Pubmed 27488531
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27301722
  • Laboratory of Cancer Biology and Genetics, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Department of Dermatology, Cutaneous Biology Research Center, Massachusetts General Hospital, Charlestown, MA, USA. · Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. · Developmental Therapeutics, Cancer Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Medicine and Dermatology, University of Arizona Cancer Center, Tucson, AZ, USA. · Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA. · Department of Dermatology, Knight Cancer Institute Melanoma and Skin Cancer Program, Oregon Health Science University, Portland, OR, USA. · Molecular Oncology Program, Melanoma Laboratory, CNIO, Madrid, Spain. · Department of Dermatology, Huntsman Cancer Institute, Salt Lake City, UT, USA. · Bascom Palmer Eye Institute and Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. · Department of Dermatology, Stanford University Medical Center and Cancer Institute/VA Palo Alto Health Care System, Palo Alto, CA, USA. · Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA. · Department of Dermatology and Dermatopathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Dermatology, University of Zurich, Zürich, Switzerland. · Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Melanoma and Skin Cancer Program, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Pathology, Cancer Center, Yale University, New Haven, CT, USA. · Department of Medical Oncology and Dermatology, University of California Los Angeles, Los Angeles, CA, USA. · Melanoma Institute, University of Sydney, Sydney, NSW, Australia. · Department of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Vic., Australia. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical School, Nashville, TN, USA. · Department of Tumor Biology, The Moffitt Cancer Center & Research Institute, Tampa, FL, USA. · Women Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. · Melanoma Program, Department of Dermatology, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC, USA. · Melanoma and Pigmented Lesion Center, Massachusetts General Hospital, Charlestown, MA, USA. · Department of Dermatology, University of Bonn, Bonn, Germany. · Melanoma Research Foundation, Washington, DC, USA. · Tumor Initiation and Maintenance Program, Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA. · Pubmed 27087480
  • Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University Philadelphia, Pennsylvania, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. · Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University Philadelphia, Pennsylvania, USA; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Electronic address: · Pubmed 26967478
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Dermatology, School of Medicine, Keio University, Tokyo, Japan. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Molecular Oncology, John Wayne Cancer Institute, Saint John's Health Center, Santa Monica, California. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology and Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26783288
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Chicago, Chicago, Illinois. · Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26645196
  • IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Unit of Medical Oncology and Innovative Therapy, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione G. Pascale", Via Mariano Semmola, 80131, Naples, Italy. · Department of Oncology and Hematology, St. Luke's University Hospital and Temple University, Bethlehem, PA, USA. · IRCCS Istituto Nazionale Tumori, Fondazione "G. Pascale", Naples, Italy. · Nanostring Inc., 500 Fairview Avenue N, Seattle, WA, 98109, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Departments of Radiation Oncology and Pathology, Weill Cornell Medical College, New York, NY, USA. · Skin Cancer Unit, Department of Dermatology, University Hospital Zürich, 8091, Zurich, Switzerland. · Gustave Roussy Cancer Campus Grand Paris, Villejuif, France. · Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. · Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA. · Departments of Medicine and of Pathology, Immunology and Cancer Program, The University of Chicago Medicine, Chicago, IL, USA. · Department of Dermatology, Center for Dermato Oncology, University of Tübingen, Tübingen, Germany. · Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. · Georgia Regents University Cancer Center, Georgia Regents University, Augusta, GA, USA. · Yale University School of Medicine, New Haven, CT, USA. · Departments of Medicine and Molecular and Medical Pharmacology, David Geffen School of Medicine and Jonsson Comprehensive Cancer Center at the University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. · Unit of Cancer Genetics, Institute of Biomolecular Chemistry, National Research Council, Sassari, Italy. · Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA. · Department of Medicine, Early Phase Clinical Trials Program, Roswell Park Cancer Institute, New York, NY, USA. · University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA. · University of Chicago, Chicago, IL, USA. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, NIH, Bethesda, MD, USA. · Departments of Medicine, Immunology and Dermatology, University of Pittsburgh, Pittsburgh, PA, USA. · Department of Dermatology, Johns Hopkins University SOM, Baltimore, MD, USA. · Istituto Europeo di Oncologia, Milan, Italy. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Genomic Medicine and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Gustave Roussy Cancer Center, U1015 INSERM, Villejuif, France. · University Paris XI, Kremlin Bicêtre, France. · Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA. · Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA. · Cancer Diagnosis Program, National Cancer Institute, NIH, Bethesda, MD, USA. · Pubmed 27846884
2015
  • The University of Texas, MD Anderson Cancer Center, Houston, Texas. · Pubmed 27058849
  • The University of Texas MD Anderson Cancer Center, Houston, Texas. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Sarah Cannon Research Institute at HealthONE, Denver, Colorado. · Eisai Inc., Oncology, Woodcliff Lake, New Jersey. · Former employees of Eisai Inc., Woodcliff Lake, New Jersey. · Mary Crowley Cancer Research Center, Dallas, Texas. · Pubmed 26169970
  • Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. · Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, Montréal, Canada. Department of Oncology, McGill University, Montréal, Canada. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, NCI, Bethesda, Maryland. · Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. · Cancer and Cell Biology Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · Departments of Dermatology and Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California. · Pubmed 26603897
  • Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Hormel Institute, University of Minnesota, Austin, MN 55912, USA. · Department of Chemistry, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. · Department of Oncological Sciences, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Department of Surgery, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA; Huntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, UT 84112, USA. Electronic address: · Pubmed 26565903
  • Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26216417
  • Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York. · Department of Biological Regulation, Weizmann Institute of Science, Rehovot, Israel. · Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · ImmunoGen, Inc., Waltham, Massachusetts. · The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York. The Interdisciplinary Melanoma Cooperative Group, New York University School of Medicine, New York, New York. · Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. · Pubmed 26206558
  • Department of Cancer Biology and Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA, USA. · Pubmed 26176707
  • University of Texas MD Anderson Cancer Center, Houston, TX, 77030, U.S.A. · Pubmed 26174638
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Electronic address: · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030. Electronic address: · Pubmed 26058727
  • Department of Melanoma Medical Oncology, Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25877344
  • Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25795007
  • Department of Pathology and Laboratory Medicine, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The Eli and Edythe L. Broad Institute of Massachusetts, Institute of Technology and Harvard University, Cambridge, Massachusetts, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25754356
  • Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, California. · Division of Cancer Epidemiology and Genetics, Laboratory of Translational Genomics, NCI, Bethesda, Maryland. · Cancer and Cell Biology Division, The Translational Genomics Research Institute (TGen), Phoenix, Arizona. · Department of Dermatology, Yale University, School of Medicine, New Haven, Connecticut. Department of Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Department of Dermatology, Yale University, School of Medicine, New Haven, Connecticut. · Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University, School of Medicine, New Haven, Connecticut. · Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, California. · Pubmed 25712345
  • Department of Dermatology, Yale University, New Haven, CT 06510, USA. Electronic address: · Department of Dermatology, Yale University, New Haven, CT 06510, USA; Department of Pathology, Yale University, New Haven, CT 06510, USA. · Department of Pathology, Yale University, New Haven, CT 06510, USA. · Department of Chemistry, Yale University, New Haven, CT 06510, USA. · Department of Emergency Medicine, The Warren Alpert Medical School of Brown University, Providence, RI 02912, USA. · Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT 06510, USA. · Section of Comparative Medicine, Yale University School of Medicine, New Haven, CT 06510, USA. · Department of Dermatology, Yale University, New Haven, CT 06510, USA. · Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA 19140, USA. · NextGen Sequencing Facility, Vermont Cancer Center, University of Vermont, College of Medicine, Burlington, VT 05405, USA. · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biology, McGill University, Montreal, QC H3G OB1, Canada. · Helen Diller Family Comprehensive Cancer Center and Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA. · Laboratory of Cancer Biology and Genetics, National Cancer Institute, Bethesda, MD 20892, USA. · Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA 02114, USA. · Department of Dermatology, Yale University, New Haven, CT 06510, USA; Department of Pathology, Yale University, New Haven, CT 06510, USA. Electronic address: · Pubmed 25584893
  • Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Dermatology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Cancer Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Experimental Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. Electronic address: · Pubmed 25148578
2014
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 904, Houston, TX 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 904, Houston, TX 77030, USA. Electronic address: · Pubmed 24880945
  • Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States. Electronic address: · Pubmed 24291778
  • Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · 1] Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA [2] Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 23416974
  • Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America. · Division of Surgical Oncology, Massachusetts General Hospital, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America. · Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America. · Department of Surgical Oncology and Genomic Medicine, University of Texas, M.D.Anderson Cancer Center, Houston, Texas, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Division of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Division of Hematology Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America. · Harvard Medical School, Boston, Massachusetts, United States of America; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, United States of America. · Pubmed 24983357
  • Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Melanoma Institute of Australia and Westmead Hospital, Sydney, Australia. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pediatrics, University of Cincinnati, Cincinatti, Ohio. · Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Bioinformatics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Astra Zeneca, Macclesfield, United Kingdom. · Departments of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. Department of Systems Biology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Pubmed 25297634
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25165098
  • Department of Genomic Medicine The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People's Republic of China. · Department of Cancer Biology The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Systems Biology The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Dermatology The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Melanoma Medical Oncology The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Institute for Applied Cancer Science The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 25056119
  • Department of Cancer Biology and Kimmel Cancer Center; Jefferson College of Graduate Studies; · Department of Cancer Biology and Kimmel Cancer Center; · Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas; and. · ImmunoGen, Inc., Waltham, Massachusetts. · Department of Cancer Biology and Kimmel Cancer Center; Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, Pennsylvania; · Pubmed 25035390
  • Departments of Melanoma Medical Oncology and Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24795008
  • The Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland, Australia. · Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, USA. · Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · NIH Intramural Sequencing Center, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Division of Medical Oncology, University of Colorado School of Medicine, Aurora, Colorado, USA. · The Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. · Genome Informatics Section, Genome Technology Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. · The Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. Electronic address: · Pubmed 24008424
2012
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22453015
  • Department of Surgery, Duke University, Durham, NC. · Department of Pathology, Duke University, Durham, NC. · Cancer Center Biostatistics, Duke University, Durham, NC. · Department of Surgery, Memorial Sloan Kettering Cancer Center, New York. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, Texas. · Department of Systems Biology, MD Anderson Cancer Center, Houston, Texas. · VA Medical Center, Durham, NC. · Pubmed 22549288
  • Departments of Melanoma Medical Oncology, Systems Biology, Biostatistics, Pathology, Experimental Therapeutics, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22223528
2011
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 7455 Fannin, 1SCRB2.3019, Unit 0904, Houston, TX 77054, USA. · Pubmed 21111965
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 20960525
2010
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 20697348
2008
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. · Pubmed 18813315
2017
  • From the Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 28114258
  • aThe Hormel Institute, University of Minnesota, Austin, Minnesota bDepartment of Medicine and Abramson Cancer Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania Departments of cOncological Sciences dSurgery eDermatology fHuntsman Cancer Institute, University of Utah Health Sciences Center, Salt Lake City, Utah gDepartment of Tumor Biology, Tumor Biology hDepartment of Cutaneous Oncology, Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida iDepartment of Medicine, Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital jDepartment of Global Health, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, DC kDepartment of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 29076949
2016
  • Departments of aMelanoma Medical Oncology bBiostatistics cSystems Biology, UT MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 27540836
  • From the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl); · the Department of Pathology, University of Michigan Hospitals, Ann Arbor (Dr Andea); · the Department of Pathology, University of Nebraska Medical Center, Omaha (Dr Bridge); · the Department of Pathology, Indiana University, Indianapolis (Dr Cheng); · the Departments of Melanoma Medical Oncology and Systems Biology (Dr Davies). · Pathology (Drs Lazar and Siroy), and Translational Molecular Pathology (Dr Lazar). · The University of Texas MD Anderson Cancer Center, Houston, Texas; Newport Coast Pathology Inc, Newport Beach, California (Dr Ehteshami); · the Department of Medicine and the Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia (Dr Gangadhar); · the Department of Pathology, The University Health Network/Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Kamel-Reid); · the Department of Pathology, Northwestern University, Chicago, Illinois (Dr Raparia); and Cancer Registry Consultant, Sioux Falls, South Dakota (Ms Watson). · and Cancer Registry Consultant, Sioux Falls, South Dakota (Ms Watson). · Pubmed 26340412
2015
  • Departments of *Surgery †Radiation Oncology and Biomedical Engineering, Duke University, Durham, NC; and ‡Departments of Melanoma Medical Oncology and Systems Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX. · Pubmed 24646553
2014
  • aHealth Science Center, University of Oklahoma, Oklahoma City, Oklahoma Departments of bMelanoma Medical Oncology cPalliative Care and Rehabilitative Medicine dBiostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24743052
  • Authors' Affiliations: Departments of Otolaryngology, Dermatology, Immunology, and Oncological Sciences; Division of Hematology and Oncology, Department of Medicine, Department of Otolaryngology, The Tisch Cancer Institute, Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai; The Tisch Cancer Institute; Department of Genetics and Genomic Sciences, One Gustave L. Levy Place, New York, New York; and Departments of Melanoma Medical Oncology and Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24398473
  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 24259006
2013
  • Authors' Affiliations: Departments of Genomic Medicine, Melanoma Medical Oncology, and Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 24089444
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22972589
  • Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 23922205
  • Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 23273605
  • Departments of Melanoma Medical Oncology and Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23204132
2012
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22275506
  • Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23032743
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22809251
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22850568
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22733540
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 22584956
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22465753
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22180178
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22171948
  • Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 22130161
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22020736
  • Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030-4009, USA. · Pubmed 21792892
2010
  • Departments of Melanoma Medical Oncology and Systems Biology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20457136
  • Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20959481
  • Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20215556
2009
  • Department of Melanoma Medical Oncology and Department of Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19671763
Miscellaneous institutions in Sao Paulo
2016
  • Department of Cell and Molecular Biology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · National Institute of Science and Technology in Stem Cell and Cell Therapy and Center for Cell-Based Therapy, Ribeirão Preto, São Paulo, Brazil. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Clinical Oncology, Stem Cell and Cell Therapy Program, Ribeirão Preto Medical School, Ribeirão Preto, São Paulo, Brazil. · Department of Genetics, Ribeirão Preto Medical School, and Center for Integrative System Biology (CISBi-NAP/USP), University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · Pubmed 27167340
Miscellaneous institutions in Ribeirao Preto
2016
  • Department of Cell and Molecular Biology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · National Institute of Science and Technology in Stem Cell and Cell Therapy and Center for Cell-Based Therapy, Ribeirão Preto, São Paulo, Brazil. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America. · Clinical Oncology, Stem Cell and Cell Therapy Program, Ribeirão Preto Medical School, Ribeirão Preto, São Paulo, Brazil. · Department of Genetics, Ribeirão Preto Medical School, and Center for Integrative System Biology (CISBi-NAP/USP), University of São Paulo, Ribeirão Preto, São Paulo, Brazil. · Pubmed 27167340
Unspecified
2014
  • Departments of Melanoma Medical Oncology, · Pathology. · Novartis Institutes for Biomedical Research, Emeryville, California; and. · Division of Medical Genetics, Department of Medicine, The University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania. · Systems Biology and. · Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; · Departments of Melanoma Medical Oncology. · Departments of Melanoma Medical Oncology, Systems Biology and. · Pubmed 24803579
2016
  • From the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl); · the Department of Pathology, University of Michigan Hospitals, Ann Arbor (Dr Andea); · the Department of Pathology, University of Nebraska Medical Center, Omaha (Dr Bridge); · the Department of Pathology, Indiana University, Indianapolis (Dr Cheng); · the Departments of Melanoma Medical Oncology and Systems Biology (Dr Davies). · Pathology (Drs Lazar and Siroy), and Translational Molecular Pathology (Dr Lazar). · The University of Texas MD Anderson Cancer Center, Houston, Texas; Newport Coast Pathology Inc, Newport Beach, California (Dr Ehteshami); · the Department of Medicine and the Abramson Cancer Center, Hospital of the University of Pennsylvania, Philadelphia (Dr Gangadhar); · the Department of Pathology, The University Health Network/Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Kamel-Reid); · the Department of Pathology, Northwestern University, Chicago, Illinois (Dr Raparia); and Cancer Registry Consultant, Sioux Falls, South Dakota (Ms Watson). · and Cancer Registry Consultant, Sioux Falls, South Dakota (Ms Watson). · Pubmed 26340412
27 Other Locations Show
Yearly article counts 11916161681956210
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.